Publications

Export 15 results:
Sort by: Author Title Type [ Year (Desc)]
2016
DARWISH, H. A. N. A. N., A. Sakr, W. Basaam, and A. Ghorab, "10 years Experience in the Treatment of Gastric Cancer: A Single Egyptian Cancer Center (NEMROCK).", Pan Arab Journal of Oncology, vol. 9, issue 3, 2016. Abstract
n/a
Alsirafy, S., O. Zaki, A. Sakr, D. Farag, W. El-Sherief, and A. Mohammed, "Predicting the Survival of Egyptian Patients with Incurable Gastrointestinal Malignancies Using the Chuang's Prognostic Score", Palliative Medicine, vol. 30, issue 6, pp. NP93, 2016. Abstract
n/a
Alsirafy, S. A., O. Zaki, A. Y. Sakr, D. E. Farag, W. A. El-Sherief, and A. A. Mohammed, "The use of the Chuang's prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy", Indian journal of palliative care, vol. 22, issue 3: Medknow Publications, pp. 312, 2016. Abstract
n/a
2014
Elghonemy E, Selim H, S. S. A. H., "FOLFIRINOX in Advanced Pancreatic Cancer, NEMROCK Experience", Cancer and Oncology Research, vol. 2, issue 3: Horizon Research Publishing, pp. 35-41, 2014. Abstract
n/a
Okasha, H. H., M. Mansour, K. A. Attia, H. M. Khattab, A. Y. Sakr, M. Naguib, W. Aref, A. A. - M. Al-Naggar, and R. Ezzat, "Role of high resolution ultrasound/endosonography and elastography in predicting lymph node malignancy", Endoscopic ultrasound, vol. 3, issue 1: Medknow Publications, pp. 58, 2014. Abstract
n/a
2013
AbdelKader, Y., T. El-nahas, and A. Sakr, "Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens", OncoTargets and therapy, vol. 6: Dove Press, pp. 1073, 2013. Abstract
n/a
Selim, H., M. Abdalla, A. Sakr, and T. ElNahas, Cisplatin plus Gemcitabine in patients with inoperable or metastatic pancreatic cancer, , 2013. Abstract
n/a
AbdelKader, Y., T. Le Chevalier, T. El-nahas, and A. Sakr, "Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation", OncoTargets and therapy, vol. 6: Dove Press, pp. 803, 2013. Abstract
n/a
AbdelKader, Y., M. Spielmann, T. El-nahas, A. Sakr, and H. Metwally, "Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer", Breast Cancer: Targets and Therapy, vol. 5: Dove Press, pp. 37, 2013. Abstract
n/a
2012
Khedr, S. A., M. A. Hassaan, and N. M. A. Razek, "Diagnostic impact of echo planar diffusion-weighted magnetic resonance imaging (DWI) in musculoskeletal neoplastic masses using apparent diffusion coefficient (ADC) mapping as a quantitative assessment tool", The Egyptian Journal of Radiology and Nuclear Medicine: Elsevier, 2012. Abstract
n/a
Mostafa, M., H. Atif, M. Fawzy, A. Y. Sakr, and A. Alashwah, "Gemcitabine versus cisplatin concurrent with radiation therapy in locally advanced head and neck squamous cell carcinoma", ASCO Annual Meeting Proceedings, vol. 30: AMER SOC CLINICAL ONCOLOGY, pp. 5557, 2012. Abstract
n/a
2011
Nady, M. E., and A. Sakr, Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion, : European Respiratory Society, 2011. Abstract
n/a
2010
Lobna Ezz-Elarab, Hany M. Abdel-Aziz, A. A. M., "Docetaxel, Cisplatin and Fluorouracil (DCF) versus Epirubicine, Cisplatin & Fluorouracil (ECF) as a first-line therapy in advanced gastric carcinoma patients", Pan Arab Journal of Oncology, vol. 61, pp. 32, 2010. Abstract
n/a
2008
Elghazaly, H., H. Tawfik, M. Mahrous, M. M. Meshref, A. Sakr, and N. Haddad, "Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: final results of a multicentric trial in Egypt", Journal of Clinical Oncology, vol. 26, issue 15_suppl: American Society of Clinical Oncology, pp. 1125-1125, 2008. Abstract
n/a
2002
Sakr, A. Y., O. E. Zaki, W. H. El-metenawy, and M. A. Aboul-enein, "Prognostic significance of elevated serum Her2 levels in breast cancer", Annals of Oncology, vol. 13: Annals of Oncology, pp. 36, 2002. Abstract

n/a

Tourism